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Exendin-4 (Ex4), a 39-amino acid polypeptide secreted by the lizard Heloderma suspectrum, shares 
common bioactivity with the human incretin glucagon-like peptide-1 (GLP-1).1 Both Ex4 and GLP-1 bind to the 
GLP-1 receptor (GLP-1R) and potentiate the secretion of insulin from pancreatic β-cells.2,3 Because of its high 
binding affinity and extended in vivo half-life, Ex4 and its analogues have been a focus for the treatment of 
type2 diabetes.4−7 
The structure of Ex4 has been determined by both 1H NMR spectroscopy and X-ray crystallography.8,9 
Because the solubility of Ex4 inH2Ois limited, its NMR spectra have been acquired in a 30% trifluoroethanol 
(TFE)/70% H2O mixture8 while the X-ray structure of a truncated Ex4 [Ex4(9−39)] has been determined in a 
GLP-1R-bound state.9 Ex4 displays significant helicity from residue 7 to 28 with greater fraying at the N-
terminus and is stabilized by a Trp cage (TC) tertiary fold at the C-terminal part of the helix. The comparison of 
the NMR and X-ray structures reveals that the TFE/H2O medium can mimic the receptor bound state as the two 
types of Ex4 conformers superimpose well. 
The N-terminal segment of Ex4 is 82% homologous with human GLP-1(7−36); conserved residues 
include His1, Glu3, Thr5, and Phe6, all of which are crucial for receptor activation (Figure 1).10−12 The affinity of 
Ex4 for the GLP-1 receptor’s N-terminal domain (nGLP-1R) is governed by the central helical part of the 
molecule.13 Both hydrophobic and hydrophilic side chains are involved in the binding as revealed by the crystal 
structure of the complex [Protein Data Bank (PDB) entry 3C5T].9 The binding surface of Ex4 consists of Glu15, 
Val19, Arg20, Phe22, Ile23, Leu26, Lys27, and Ser32, whereas that of nGLP- 1R involves Leu32, Thr35, Val36, Trp39, 
Tyr69, Tyr88, Leu89, Pro90, Trp91, Leu123, Glu127, and Glu128.9 
On the basis of recent structure−activity studies, it is known that all peptidic ligands targeting class B 
G-protein-coupled receptors (GPCRs) bind in a predominantly α-helical manner, and for most ligands, the α-
helix forms upon binding of the extracellular N-terminal domain of the GPCR.15 These ligands, including 
glucagon,16 GLP-1,8,17 GLP-2,18 Ex4,8 glucose dependent insulinotropic polypeptide (GIP),19 pituitary adenylate 
cyclase activating polypeptide (PACAP),20 and corticotropin- releasing factor (CRF),21 show moderately ordered 
structure in aqueous solution but adopt a continuous or kinked α-helix in the presence of organic solvents (e.g., 
in a TFE/water mixed solvent) or in protein crystals. The major structural difference between Ex4 and GLP-1 is 
the continuity of the α-helix: Ex4 forms a single amphipathic α-helix both in the TFE/water mixed solvent and in 
the receptor-bound state, while GLP-1 is composed of two adjacent subhelices joined by the flexible Gly22. 
Binding studies demonstrated that the isolated N-terminal extracellular domain of GLP-1R has a low affinity for 
endogenous GLP-1 but a high affinity for Ex4.22 The superior affinity of Ex4 stems from the more favorable 
alignment of the oppositely charged hydrophilic residues at the receptor binding site and from the enhanced α-
helical propensity of Ex4 in solution.9,23 Previous studies found a positive correlation between the α-helical 
propensity of the ligand and its affinity for nGLP-1R.23 It was proposed that the C-terminal extension of Ex4, 
which is absent in GLP-1, has only a minor role in mediating receptor binding; thus, this segment cannot be the 
source of the high binding affinity. However, we suppose that the latter nine-residue C-cap, PSSGAPPPS, has a 
definite role in fine-tuning the structure of the Ex4 α-helix and in preforming the receptor bound conformation in 
solution. We propose that the extension described above makes the TC fold an ideal C-cap of a more stable α-
helix.12,22,24,25 
Studies of the aggregation ability of different class B GPCR ligands (e.g., calcitonin,26,27 glucagon,28 or 
GLP-129) determined that these peptides can form cytotoxic amyloid aggregates that could be a drawback for 
their usage as protein drugs. In liquid formulations, these peptides tend to self-associate and assemble into 
transient helix bundles25 and over time form aggregates.30 Of particular concern is the fact that the peptide 
aggregates increase the risk of immunogenicity.31 Therefore, chemical modifications (e.g., site specific mutations 
or side-chain conjugation) need to be considered to obtain therapeutic candidates that are more soluble, more 
stable, and thus safer than the existing drug. 
Following these guidelines, we designed Ex4 analogues, including a potential GLP-1R agonist (E19) 
and several antagonists (E0−E11), using the optimized TC miniprotein as a starting sequence.32,33 The procedure 
incorporated the replacement of specific residues into the Ex4 sequence to increase the peptide’s helicity and 
meanwhile reduce its ability to self-assemble. As a result of this design, E19 is now more soluble in pure water, 
less prone to aggregation, and under all conditions more helical than Ex4. Moreover, it shows an insulin 
secreting activity comparable to that of Ex4. 
 
RESULTS 
 
The parent molecule of our study was the 20-residue Trp cage miniprotein (NLYIQ WLKEG 
GPSSG RPPPS), originally derived from Ex4 by truncating its first 19 N-terminal residues and by 
modifying the remaining sequence at five structurally essential positions.32,33,47 During the design 
process, we applied this structurally optimized TC motif now as part of Ex4, to enhance the overall 
helicity and water solubility of the nGLP-1R agonist. Rational protein design involved the insertion of 
a Glu28−Arg35 salt bridgea and the replacement of Phe22 and Glu24 with Tyr22 and Gln24, respectively. 
The N28E and A35R modifications of the Ex4 sequence have multiple benefits. (i) The salt bridge 
stabilizes the overall structure, thereby increasing the folded population and improving the helicity.32,33,47,48 (ii) 
The side chains of the salt bridge-forming residues cover the indole ring of Trp25; thus, they reduce the water-
accessible hydrophobic surface area. (iii) The charged side chains of Glu28 and Arg35 improve the peptide’s water 
solubility. The F22Y modification improved the π−π stacking interaction with Trp25 and increased the 
hydrophilicity of the peptide.32 This modification also allowed the monitoring of the compactness of the 
hydrophobic core (Trp → Tyr interaction) with near-UV ECD measurements. Although Phe22 is a highly 
conserved residue that directly interacts with the receptor, we surmise that the phenolic OH will not undermine 
the peptide’s affinity for nGLP-1R because other class B GPCR ligands (e.g., VIP and PACAP) have a Tyr 
residue at this position (Figure 1).49 The E24Q mutation was incorporated to avoid an unfavorable electrostatic 
interaction between Gln24 and Glu28 in the α-helix.32 
In our study, we first analyze the ECD andNMRspectra of Ex4 and 14 TC elongated variants to assess 
the structural consequences of the introduced sequence modifications. Next, we evaluate the structural changes 
as a function of backbone mobility via 15N relaxation measurements. Subsequently, wepresent the results of the 
diffusion-ordered (DOSY) NMR measurements and compare the self-association property and thus the water 
solubility of Ex4 and E19. Finally, we analyze the preliminary data regarding the in vivo insulin secreting ability 
of Ex4, E19, and E10 peptides. 
 
E19 Is More Helical Than Ex4.  
 
Panels a and b of Figure 2 show the far-UV ECD spectra of all the investigated polypeptides. The Trp 
cage elongated variants (E0−E11) were measured at 5 °C in pureH2O, while Ex4 and E19 were measured in 
both H2O and a 30% TFE solution. The comprehensive ECD spectral analysis revealed unexpectedly large 
structural changes as a function of the length of the polypeptide chain (E0−E19). The ECD spectra of Ex4, TC, 
and all the elongated variants from E4 to E19 display a C-type ECD curve with a positive maximum at around 
190 nm and twobminima at 208 and 222 nm. This characteristic ECD spectrum is often associated with α- and 
310-helices as well as with repeated type I (or III) β-turns. On the other hand, the ECD spectra of E0−E3 indicate 
a decreased C-type and an increased U-type ECD curve propensity. The U-type curve indicates a structural 
ensemble of elevated internal dynamics. The ECD studies suggest that the apparent change in the helical 
propensities among different peptides is more the consequence of the shift between conformational populations 
(folded ⇌ unfolded) than the change of the structure types in the dynamic ensemble. Thus, the more intense the 
C-type ECD curve, the larger the peptide’s folded fraction. 
With the extension of E0 (resulting in E1, E2, etc.), the folded fraction gradually increases; however, 
the latter increase is not monotonic. Three constructs, namely, E5, E9, and E11, seem to be more helical than 
their N-terminal elongated partners, E6, E10, and E19, respectively (see the inset of Figure 2a). While E11 is the 
most helical construct among all 15 studied peptides ([Θ]191 = 49.5 × 103 deg cm2 dmol−1, [Θ]222 = −24.2 × 103 
deg cm2 dmol−1, and [Θ]208 = −21.3 × 103 deg cm2 dmol−1), E19 presents a helicity similar to that of E7. E19 is 
less helical (or apparently less stable) than E11 because of the elevated internal mobility of the first eight N-
terminal residues that were added in one step to E11 to make E19. Note that the latter eight residues must be 
unstructured to successfully activate the GLP-1 receptor,  and thus, they will decrease the overall helicity of any 
agonist.50 Because Ex4 shows a modest level of aggregation in aqueous solution,8 we also measured its ECD 
curve in a 30% TFE solution and compared it to that of E19 (Figure 2b). Clearly, E19 has superior helicity in the 
presence and absence of the added fluoro alcohol medium; the relative increase in helical content is 21% in H2O 
and 31% in 30% TFE (measured as [Θ]E19222/[Θ]Ex4 222 − 1 and expressed in percent). The ECD study implies 
that the optimized TC motif can indeed be used to stabilize the overall fold and increase the α-helical propensity 
of Ex4-related peptides. 
 
The Optimized TC Motif Stabilizes the α-Helix of Ex4. 
 
The results of the ECD spectral analysis were supplemented with homonuclear NMR measurements; 
similar stability differences were observed throughout the studied sequences now obtained and analyzed at the 
atomic level of detail.  Figure 3 and Figures S2 and S3 of the Supporting Information display the Hα chemical 
shift deviation (CSD) plots of the studied peptides together with the NOE connectivity chart of E19 (all other 
NOE charts are displayed in the Supporting Information). Generally, the negative Hα CSDs and the dense i,i + 3 
and i,i + 4 NOE network indicate α-helical secondary structure for all peptides for almost all residues in the 
D9−E28 segment. However, there are three Hα protons (E17, L21, and Q24) with remarkably downfield 
chemical shifts and one (L26) with upfield chemical shifts. L21, Q24, and L26 Hα CSs are perturbed by the ring 
current effect of the neighboring W25 aromatic residue because the two former protons lie in the plane of the 
indole ring while L26 Hα lies right above it. On the contrary, for spatial reasons E17 Hα must be unaffected by 
the W25 ring current because the distance between E17 Hα and the closest indole carbon (W25 Cγ) is ∼13 Å; 
therefore, the close to zero CSD indicates that the continuous α-helix has a kink point at this residue. 
Division of the central α-helix into two helical subsets is in excellent agreement with the GLP-1 
structure17 where the Nterminal random coil segment (residues H7−S14) is followed by two helical segments 
(N-helix of S14−E21 and C-helix of A25− G36) that are connected by a linker region (G22−A24). This linker 
provides flexibility for the long α-helix to access the nGLP-1R binding site.14 Therefore, in Ex4 and E19, E17 
has a role similar to that of the linker region in the GLP-1(7−37) α-helix.17 Here, the N-helix spans residues 
D9−E16, while the C-helix spans A18−E28. 
Residues in the C-helix show much larger Hα chemical shift deviations than the residues in the N-helix 
(Figure 3). Via inspection of the structure of E19 (Figure 4m), it is evident that as the C-terminal PPII helix folds 
back toW25 it interacts with the C-helix (several NOEs connect the two regions), while it has a minor direct 
effect on the N-helix (no NOEs are found between the C-terminal segment and the N-helix). The C-helix and the 
PPII helix together form the TC motif (A18−S39), and thus, the TC motif serves as an ideal C-cap for the helical 
core. 
The helix inducing ability of the TFE/water mixed solvent was studied by comparing theHα CSDs of 
E19 measured inH2Oand in 30% TFE and that of Ex4 measured in 30% TFE (Figure S3 of the Supporting 
Information). There is less difference between the spectra of E19(30%TFE) and Ex4(30%TFE) than between 
E19(H2O) and E19(30%TFE), implying that the four mutations that distinguish E19 from Ex4 have a weaker 
effect on the overall structure than the solvent composition does. Remarkably, the Hα CSD pattern of the C-helix 
of E19 is slightly perturbed; the Hα CSDs of Y22, I23, W25, and L26 are reduced by ∼0.1 ppm, while that of 
K27 is increased by ∼0.05 ppm as the TFE is added to the solution. Also, a change can be observed in the 
helicity of the N-helix, where S11, M14, E15, and E16 become more helical (Hα CSD reduced by ∼0.08 ppm). 
These effects are ascribed to the ability of TFE to stabilize helical conformations in peptides while disrupting the 
hydrophobic interactions of native proteins.51 Following Barua et al., we use CSDcage and CSDhelix values to 
compare the relative stabilities of the different TC variants.52 Table 1 and Table S1 of the Supporting 
Information list the calculated CSD values and the derived relative folded fractions χF. 
On the basis of the CSDhelix and χF(helix) values, the most helical studied peptide is E10 with an 
apparent 100% helix population (same helicity as the folded reference construct). This seemingly contradicts the 
ECD data where E11 was the most helical peptide; however, the two methods measure the helicity in two 
different ways: ECD measures an ellipticity value to which the whole molecule contributes (n → π* band of the 
amide bonds), while the CSDhelix-derived χF value reports on the helicity of the TC motif itself. In general, we 
conclude that the overall helicity of these peptides gradually increases from E0 to E11, while the further 
elongation (E11 → E19) does not further improve the helicity. In fact, E19 has a fold stability [χF(cage) and 
χF(helix)] similar to that of E11, originating from the similar helical propensity as discussed above. 
In E0, the N-terminal Asn → Arg substitution strongly destabilized the structure: χF(cage) and χF(helix) 
decreased from 86 to 25% and from 78 to 30%, respectively (Table 1). In the NMR spectra of E0, some slowly 
exchanging additional peaks appeared beside the main set of resonances (e.g., Y22 Hε#, W25 Hδ1, and W25 
Hε1). The presence of peaks associated with the TC minor conformer was observed before under acidic 
conditions.34,48 Many characteristic NOEs (Y22 Hδ#−P38 Hγ#; W25 Hδ1−R35 Hβ#,Hγ#; W25 Hη,Hζ2−P31 Hγ#; 
W25 Hε1−P36 Hα; etc.) indicate, however, that the folded 3D structure is still preserved in E0, but highly 
destabilized. The destabilization stems from the repulsion between the partial positive charge of the helix 
macrodipole at the N-terminus co-located with the positively charged Arg residue. On the other hand, the 
introduction of a negatively charged aspartate at the N-terminus of the Trp cage (e.g., as Asp1 in Tc10b, 
DAYAQWLKDGGPSSGRPPPS) is highly favorable.52 This is in line with the general observation that the 
helical content of model peptides (e.g., NH2-XAKAAAAKAAAAKAAGY-CONH2) decreases as the N-terminal 
amino acid becomes more positive.53 The TC fold stability is restored during the gradual N-terminal elongation. 
Both the helix [χF(helix)] and the cage [χF(cage)] populations increase by ∼5−10% for each of the added 
residues, resulting in E1−E3 (Table 1). Although E3 is stabilized by the Nterminal negatively charged glutamate 
(Glu17), it is still less stable than the shorter TC. However, the tendency is clear, and the stability is fully 
restored by the addition of the next glutamate (Glu16) to the N-terminus, resulting in E4. In E4, Glu16 acts as an 
N-cap while Glu17 as a salt bridge-forming side chain interacting with Arg20. χF(cage) increases further in E5 
and reaches ∼90%. The next five constructs (E6−E10) have similar NMR spectral properties in terms of CSD 
and NOE patterns. The helix extension does not affect the folded population further: χF(cage) ranges between 92 
and 97%. In E8, the positively charged Nterminal Lys12 does not destabilize the α-helix as Arg20 did in E0: it 
rather forms a salt bridge with either Glu15 or Glu16, and the interaction shields the unfavorable positive charge 
at the terminus. Interestingly, E10 seems to be especially stable in comparison to E9 or E11; its helix population 
reaches the theoretical maximum [χF(helix) = 1; i.e., E10 has the same helicity as the folded reference molecule], 
and the cage population is 97%. However, this exceptional stability was not apparent in the ECD measurements, 
as the latter method measures the content of the secondary structural elements (e.g., α-helix) rather than the fold 
compactness. Via comparison of the folded fractions of Ex4(30%TFE) and E19(30%TFE), it becomes apparent 
that E19 has a stabilized fold with superior helicity and compactness [χF(cage) and χF(helix), as these values 
increase by ∼10% in E19(30%TFE) with respect to those in Ex4(30%TFE)]: 0.74 < χF(cage) < 0.89, and 0.77 < 
χF(cage) < 0.87. Note that there is only minor difference in the χF(cage) and χF(helix) values between the E19 
spectra recorded in water and in a 30% TFE solution. This implies that the TFE induces TC formation only in 
those molecules in which the TC fold is lessstable in aqueous solution (Ex4); on the other hand, it has no effect 
on variants in which the TC fold is already compact enough in water (E19). These findings corroborate the 
results of the ECD measurements. 
 
The Designed Variants Preserve the TC Structure. 
 
All N-terminally elongated variants have the same TC fold, differing only at the N-termini. The TC fold 
is characterized by a compact tertiary structure that consists of an N-terminal α-helix, followed by a 310-helix 
(Gly29−Gly34) and a short polyproline II helix (Arg35−Ser39), all organized around the central Trp25 residue. 
Here, we summarize the observed minor structural differences of E0−E11 while a more comprehensive analysis 
is given for E19. The structure refinement statistics and the number of constraints employed in the ensemble 
calculations are listed in Table 2. 
E0−E4. As discussed earlier, the Asn20 → Arg20 mutation highly destabilizes the TC structure because 
of the repulsion between the positive charge of Arg20 and the partially positive charge of the α-helix 
macrodipole at the N-terminus. In accordance with such stability loss, the total number of assignable NOEs is 
lower than the number of TCs (Table 2). The lower number of NOEs results in poorly defined structural 
ensembles for E0−E3. A ribbon representation of 10 superimposed structures with rmsds of 1.96, 2.26, 1.23, and 
1.90 Å for backbone atoms are shown in panels a−d of Figure 4, respectively. Although the variation of the 
structures is large, the TC fold is apparent, as a handful of α-helix- and Trp cagedefining NOEs are observed in 
the NOESY spectra, e.g., Y22 Hα−W25 Hβ1,Hβ2; W25 Hζ2,Hη2−P31 Hγ#; W25 Hδ1−R35 Hγ#; or W25 
Hζ2−P37 Hδ1 side-chain protons. 
The NOESY spectrum of E4 contained an adequate number of interresidual NOEs for deriving a 
structural ensemble with a low backbone rmsd (0.71 Å) (Figure 4e). Most of the characteristic long-range NOEs 
are observed. The N-terminal α-helix is one turn longer than that of TC, and a favorable Glu17−Arg20 salt 
bridge can stabilize this extended α-helix. 
E5−E11. All of these peptides show the same overall structure displaying the characteristic TC features 
(Figure 4f−l). The Nterminal α-helix gradually extends, while the TC motif remains quasi unchanged. The NOE 
patterns are consistent with a continuous α-helix: many of the expected Hαi−Hβi+3 and Hαi−Hβi+4 NOEs are 
seen spanning the α-helix from the second Nterminal residue to Glu28. The kink at Glu17 found by the CSD 
analysis is not apparent from the structures; several NOEs connect the C-terminal segment of the α-helix (C-
helix) with the N-terminal part of it (N-helix). Interestingly, the aromatic sidechain resonances of Tyr22 in E10 
were broadened, indicating that the rotation about the Cβ−Cγ axis slowed to the microsecond to millisecond time 
scale, while for all other peptides, this rotation was fast enough to give rise to single, degenerate Tyr22 Hδ# and 
Hε# resonances. E19. The sequences of E19 and Ex4 differ at four positions only; namely, Y22, Q24, E28, and 
R35 replace F22, E24, N28, and A35, respectively, of Ex4. All other residues are the same. In the PDB, both 
NMR and X-ray structures are available for Ex4; the NMR structure (PDB entry 1JRJ) was determined in a 30% 
TFE solution,8 while a truncated Ex4 [Ex4(9−39), PDB entry 3C5T] was crystallized together with the N-
terminal domain of the GLP-1R.9 
In our study, the NMR structure of E19 was determined using 774 NOE constraints (PDB entry 2MJ9); 
114 + 78 define the α- helix (i,i + 3 and i,i + 4 NOEs), and 87 define the overall structure (i,i + n,n > 4). 
However, no interresidual NOE was observed for residues of the N-terminal tail (H1−T7), fully supporting the 
idea that this segment is highly dynamic. Because of the high NOE density, the calculated structural ensemble is 
of good quality, represented by a small rmsd; the pairwise rmsd for residues 9−39 was 0.33 Å for the backbone 
atoms and 1.15 Å for all heavy atoms (Table 2). 
The presence of exchange cross-peaks of the amide protons of residues 3−16 with water in the NOESY 
spectrum suggests that in time average these amides are partially or completely solvent exposed, which agrees 
well with the CSD data suggesting that the N-terminal segment (H1−T7) is disordered and the N-helix (D9−E16) 
is less stable than the C-helix (A18−E28). These dataare well-reflected in the 10 conformers representing the 3D 
structure of E19 (Figure 4m). Continuous COi → NHi+4 hydrogen bonds are observed for residues M14−E28, 
while no single secondary structure is observed for the N-terminal tail (H1−T7). As found in the TC motif, 
residues G30−G34 prefer to be a 310-helix rather than an α-helix conformer supported by the presence of 
Hαi−HNi+2 NOEs and the absence of Hαi−Hβi+3 NOEs. Of special interest are the salt bridges connecting residues 
D9, K12, E16, and R20; the side chain of K12 and E16 can alternate to interact with the oppositely charged 
residues downstream or upstream on the α-helix face, thereby largely stabilizing the overall helical fold. 
The superpositions of the backbone atoms of the NMR structure of E19 with the NMR and X-ray 
structures of Ex4 are shown in panels a and b of Figure 5. Although the overall structures of these compared 
molecules are similar [backbone rmsds of residues 15−39 between E19 and Ex4(NMR) and between E19 and 
Ex4(X-ray) of 0.74 and 0.81 Å, respectively], some differences also emerge. The major distinction between the 
NMR structure of E19 and Ex4 is the apparent mobility and orientation of residues 5−14; Ex4(30%TFE) seems to 
be more rigid and helical here than E19(H2O). The helix of E19 is less defined because of the minimal helix-
positioning NOEs between T5 and M14. The α-helix stretches between T5 and N28 in Ex4 and between D9 and 
E28 in E19. In both peptides, the N-terminal tail is disordered, which is a prerequisite for bioactivity.50 
The differences between the E19(NMR) and Ex4(X-ray) structures become apparent when the side-
chain orientations of some helix forming residues are analyzed, particularly those of D9, K12, E17, and R20. In 
the Ex4(X-ray) structure, D9 is the first N-terminal residue with a high B factor showing no polar contact with 
the surrounding side chains. In E19 [and in Ex4(NMR)], D9 forms a helix-stabilizing salt bridge with K12. 
Similarly, E17 has no direct intermolecular interaction in Ex4(X-ray), while it forms a salt bridge with R20 in 
the E19(NMR) structure. On the other hand, in Ex4(X-ray), the side chain of R20 interacts with the side chain of 
E128 of nGLP-1R.  
 
Fold Fluctuation Determined by NMR Backbone Dynamics.  
 
Local backbone dynamics of TC, E5, E11, and E19 samples were investigated using 15N longitudinal 
(R1) and transverse (R2) relaxation rates and steady-state heteronuclear NOEs (Figure S8 of the Supporting 
Information) at 27 °C.  
These relaxation parameters were analyzed with the reduced spectral density mapping (RSDM) 
approach40,43−45 (Figure 6). The more widespread Lipari−Szabo model-free analysis54,55 was not applied because 
its assumptions do not hold for this system, particularly at marginal structural stability (e.g., TC at 27 °C), and 
the time scales of internal and overall motion are not independent; moreover, if dimerization or oligomerization 
occurs, then a single τc rotational correlation time or rotational diffusion tensor cannot describe the overall 
motion. The RSDM approach does not use any assumption regarding the time scale of motions or the shape and 
size of the molecule; therefore, it can confidently be applied to characterize even highly flexible polypeptides. 
As the length of the N-terminal α-helix increases so does the average J(0) value. This phenomenon is a 
result of the altered form of the rotational diffusion tensor. Starting from a globular TC fold, the molecule adopts 
the shape of a prolate rotor; then, it forms higher-molecular weight oligomers (vide inf ra). Besides, an elevated 
J(0) indicates sites with slow time scale backbone motion (Rex). Some residues (e.g., E15, G30, and S32 in E11 
or E16, Y22, and K27 in E19) show exceptionally increased J(0) values that could refer to microsecond to 
millisecond dynamic processes at those sites (Figure 6). 
The J(ωN) value does not seem to change substantially with the overall shape of the molecule (i.e., the 
length of the α-helix). Therefore, very similar J(ωN) values were measured for E5, E11, and E19, especially in 
the core α-helical region (Y22−G30). The apparent decrease in the J(ωN) of TC with respect to E5, E11, and E19 
reflects the fact that at 27 °C the folded fraction of TC is only ∼54% while that of E11 and E19 is ∼90% (see 
Table 1). Interestingly, for the residues in the 310-helix, the J(ωN) values increase with the length of the 
molecules (TC → E5 → E11 → E19), which indicates that motions around 50 MHz become more prevalent 
here. 
The sequence dependence of the J(0.87ωH) values corroborates the observations made for J(ωN) 
described above. TC is the most flexible molecule among the studied elongated variants; thus, it has the highest 
average J(0.87ωH). As the length of the α- helix increases, the stability of the molecules increases and their 
J(0.87ωH) value decrease. Apart from the N-terminal tail of E19, the amides of S34 and G35 are the most 
flexible in all constructs, usually more flexible than the C-terminal S39. The potential Rex contributions of E19 
relaxation was examined by combining the J(0) values measured independently at two spectrometer frequencies 
(500 and 700 MHz), and the proportionality factor (ϕ, Rex = ϕωN 2) was derived using published methods.56 A 
plot of the ϕ values versus the protein sequence (Figure 6d) indicates that there is a general increase in almost all 
J(0) values with increasing field with typical values between 10 × 10−9 and 30 × 10−9 ns rad−1. This reflects a 
widespread exchange process that affects the whole molecule such as a slow time scale dimerization or 
oligomerization. The highest ϕ values were observed for Y22, K27, and G30 in the range of 40−60 × 10−9 ns 
rad−1, which corresponds to Rex contributions of 8.9 ± 6.8, 6.8 ± 4.2, and 10.8 ± 4.6 s−1, respectively. The slow 
exchange of K27 and G30 could be in connection with the rearrangement of the 310-helix region, which is the 
initial step of TC unfolding.34 
The backbone relaxation measurements confirmed the observations of the Hα chemical shift deviation 
analysis. We found a correlation between the magnitude of the Hα CSD and the rigidity of the backbone NH 
vector (compare Figures 3 and 6c and Figure S9f of the Supporting Information). Both of these methods 
identified the N-terminal tail (H1−S8) as a flexible, unstructured segment, the N-helix (D9−E16) as a moderately 
stable, structured segment with increased mobility, and the C helix as rigid, stable, helical segment. The 
NOESY-based structure calculation does not pick up the interface between the N- and C-helix; however, as 
NOE-based calculations reflect the average structure, fast local confined backbone fluctuations are ignored. 
Thus, a combined study of chemical shifts, structure, and dynamics is needed to characterize the complex 
conformationaldynamics of a protein. These studies can be complemented with temperature-dependent folding 
measurements, and hence, the energetic aspects of the protein’s stability and flexibility can be evaluated. 
 
Ex4 Forms Higher-Order Associates Than E19 Does. 
 
Previous studies reported that both GLP-1 and Ex4 show significant self-association in vitro at close to 
physiological pH and temperature, resulting in amyloid-like fibrils (GLP-1)29,57 and broadened NMR signals 
(Ex4).8,25,58 The self-association number of the 2 mM Ex4 sample at 298 K was approximated to be three 
(trimer) in water and between two (dimer) and three (trimer) in a 30% TFE/70% H2O solution.58 To obtain the 
translational diffusion coefficients (D) and the apparent molecular mass (Mw app) of Ex4 and E19, we 
performed pseudo two-dimensional DOSY experiments at three different temperatures (5, 16, and 27 °C) in an 
aqueous solution and in a 30% TFE/70% H2O solution on 0.5 mM peptide samples. To take into account the 
differences in temperature and viscosity among different conditions, we converted the measured diffusion 
coefficients to standard conditions (20 °C, water).39 The measured diffusion coefficients (Dobs), the calculated 
standard condition diffusion coefficients (Dst), and the apparent molecular masses of E19 and Ex4 are compared 
in Table 3. As monomers, Ex4 and E19 have molecular masses of 4.2 and 4.3 kDa, respectively; thus, the 
calculated 6−28 kDa Mwapp implies that both of these molecules exist in equilibrium between multiple states with 
different self-association numbers. 
As listed in Table 3 (and shown in Figure S4 of the Supporting Information), E19 exhibits a somewhat 
larger diffusion coefficient and thus a lower apparent molecular mass than Ex4 under all six measured 
conditions. This difference is rather small, implying that only a small perturbation occurred in the intermolecular 
interactions that hold together the complexes. As expected, the self-association propensity decreases with an 
increase in temperature; in water at 5 °C, the majority of the molecules form dimers, and at 27 °C, the 
equilibrium is shifted toward the monomer. This is in line with the observed narrowing of the NMR signals at 
higher temperatures. The self-association is weak and transient and occurs relatively fast on the NMR time scale 
(intermediate exchange regime); therefore, the observed diffusion coefficient appears as the population-weighted 
average of the diffusion coefficients of the monomer, dimer, trimer, etc. A uniform dimerization with a clear 
interaction surface was not captured during the NOE-based structure determination of E19. 
No intermolecular NOEs define the relative orientation of the two (or more) interacting molecules, 
which implies that no single structure can represent the dimer or oligomer states. Most likely, the long α-helix 
represents the interacting surface because the NH amide resonances of the residues in the α-helix showed 
relatively broader resonances than those in the N-terminal tail or at the 310-helix region did. The latter finding 
was also supported by backbone relaxation measurements; the transverse relaxation rate was significantly higher 
in this region than at the unstructured N-terminal tail or at the C-terminal region (vide supra). Previous medium 
dependence studies also established that the segment spanning Gln13 and Leu26 could be responsible for 
nonspecific helix bundle formation in water and organic solvents.25 
A TFE/water mixed medium induces α-helix formation in polypeptides and thus facilitates the self-
association of both Ex4 and E19. Most probably, the TFE cosolvent favors intermolecular helix−helix interaction 
over intramolecular Trp cage formation and therefore promotes oligomerization.51 In 30% TFE at low 
temperatures, the equilibrium is shifted toward higher-order associate states (trimer ⇌ tetramer for E19 and 
pentamer ⇌ hexamer for Ex4) than in the absence of TFE (dimer⇌trimer for both E19 and Ex4), but the 
decrease in selfassociation number with temperature is more drastic in a 30% TFE solution than it is in water. 
 
E19 and Ex4 Show Comparable Insulin Stimulating Activity.  
 
The secretory responses of INS-1E cells to various GLP-1R agonist stimuli were tested in the presence 
of 15 mM glucose, over a 30 min incubation period (see Figure 7). First, we conducted a pilot glucose-stimulated 
insulin secretion study to set the conditions for the GLP-1R agonist peptide testing. We stimulated the cells with 
15 mM glucose alone and observed a maximal 2.35-fold increase in the level of insulin secretion compared to 
that with basal 2.5 mM glucose [on average, we saw a 1.79 ± 0.17-fold increase in response to 15 mM glucose (n 
= 7)]. Next, as a negative control, we tested the effect of GLP-1R agonist Ex4 at a low glucose concentration 
(2.5 mM) and could not see a substantially increased level of insulin secretion, as was expected (data not shown). 
In contrast, the level of insulin secretion was markedly increased when GLP-1R agonist Ex4 was added (20 nM) 
at a glucose concentration of 15 mM. Compared with the level of insulin release at 15 mM glucose, there was a 
2.05 ± 0.06-fold increase in the level of insulin secretion in response to 20 nM Ex4 [mean ± standard error of the 
mean (n = 9)]. As displayed in Figure 7, the insulin secreting ability of E19 is comparable to that of Ex4; 
however, it is slightly reduced relative to that of Ex4 by 15 ± 5% [statistically insignificant (n = 6)]. The 
truncation of the first nine residues of E19 converted peptide E10 to a weak antagonist or to a nonbinding 
peptide as its insulin secretion ability is comparable to that of glucose alone (p = 0.380; n = 5). However, further 
study is needed to test the nGLP-1R binding ability of E10. Previous studies established that Ex4(9−39) and 
other truncated variants of Ex4 bind the nGLP-1R with high affinity and thus act as strong antagonists in 
competitive binding studies;3,9 therefore, it is likely that E10 binds the nGLP-1R and acts as an antagonist. It is 
noteworthy that the level of insulin secretion in our cultured INS-1E cell line around passage 100−120 is 
considerably lower than what was reported previously.46 Therefore, the results should be interpreted within the 
context of this particular experiment. 
 
DISCUSSION 
 
Much effort has been spent to improve the in vivo half-life, binding affinity, and activity of the 
therapeutic antidiabetic drug Exendin-4 (Ex4) by chemical modification, either within the sequence, e.g., 
replacing α-amino acids with β-amino acids,58 or by side-chain conjugation, e.g., with fatty acids59 or 
hylauronate. 60 In this study, our goal was to stabilize its structure, improve its water solubility, and weaken its 
self-association ability to facilitate future drug formulation. Because the helicity of the peptides often correlates 
with their affinity and bioactivity, several studies attempted to stabilize the α-helix of different class B GPCR 
ligands. For instance, intramolecular lactam bridges or D-amino acids were introduced into the sequence of 
GLP-161,62 and CRF21,63 to increase the ligands’ α-helical propensity and to elucidate the optimal linkers (AAAA 
or EKEK) were incorporated into the sequence of GIP, resulting in highly potent GIP receptor antagonists.64 Our 
method for the stabilization of the α-helical conformation of Ex4 is a mild mutational approach in which the 
structurally optimized Trp cage (TC) miniprotein32,33 serves as an ideal Ccap. It has been demonstrated that the 
TC motif can be used to stabilize moderately structured α-helices when it is introduced at the C-terminus.24 Here 
we systematically increased the length of the TC motif with the corresponding amino acid residues of Ex4and 
analyzed the structural consequences (stability, dynamics, and aggregation) of such an elongation by ECD and 
NMR spectroscopy. 
First, we replaced the N-terminal Asn20 of TC with the corresponding Arg20 residue of Ex4 because 
this latter side chain is crucial for receptor binding.10 We found that this modification destabilized the fold 
because of the repulsion between the positively charged N-terminal Arg and the positively charged helix 
macrodipole. With further N-terminal elongation, the helicity gradually increased and the peptides’ structures 
were further stabilized. The 39-residue E19 is 20−30% more helical than Ex4 in both aqueous and helix-inducing 
media (30% TFE). The solution structures of Ex4 and E19 are rather similar: they include an N-terminal, highly 
flexible tail (His1−Ser8), an α-helix spanning Asp9−Lys27, and a well-formed C-terminal Trp cage motif in the 
segment of Ala18−Ser39. The only noteworthy difference appears at the N-terminal tail: in the 30% TFE 
solution, the α-helix of Ex4 begins one turn earlier than that of E19 in water. 
The nine C-terminal residues of Ex4 have very weak electron density in the nGLP-1R-bound X-ray 
structure (PDB entry 3C5T), which suggests that this segment might be in an undocked, highly fluxional state, 
and the presence of Trp cage is not necessary for the optimal receptor−ligand interaction.9 On the other hand, 
fluorescence studies of free and receptor-bound Ex4 implied that the Trp cage motif can be present at least 
partially in the nGLP-1R-bound state.23 These concerns raise the question of whether it is necessary to have a 
ligand with a flexible C-terminal tail (as in Ex4) or no tail at all (as in GLP-1) or whether the flexibility of the C-
terminal segment affects the binding affinity. Because Ex4 and E19 show comparable insulin secreting ability, 
we speculate that the nine C-terminal residues only help the preformation of the α-helix and have no role in the 
receptor−ligand interaction. 
Previous studies established that structurally destabilized TC variants (e.g., serine-phosphorylated 
variants) easily polymerize into amyloid fibrils when highly concentrated samples are incubated at 37 °C.65 
Similarly, at higher concentrations (1−30 mM), E0, E5, and E10 analogues display an irreversible α-helix→ β-
sheet folding transition,66 indicating that self-association is a general process among Trp cage and related 
polypeptides. For Ex4, the extreme, residue specific line broadening observed in the NMR spectra and the 
concentration-dependent change in its far- UV ECD spectra are also clear indications of oligomer formation.25,58 
With diffusion measurements, here we quantitatively analyzed the self-association ability of Ex4 and E19 in an 
aqueous medium as well as in a 30% TFE solution. We found that the observed level of oligomerization was 
always higher for Ex4 than for E19; that is, E19 is less prone to self-association. This observation provides 
evidence of the role of the Trp cage motif in the prevention of helix−helix interaction: oligomerization is 
initiated when the increase in energy associated with Trp cage formation is smaller than the increase in energy 
upon burial of the hydrophobic surface of the amphipathic α-helix. Thus, an energetically more favorable Trp 
cage formation (as in E19) prevents self-association. Organic cosolvents (e.g., TFE) favor α-helix over Trp cage 
formation and thus shift the equilibrium toward multimerization, and this explains the higher association number 
observed in the aqueous TFE solution. 
In summary, we propose here that the rational design of the TC head of Ex4 stabilizes the central α-
helical segments, increases 3D fold stability and water solubility, and, thus, opens new routes of creating new 
antidiabetics with lower aggregation propensities. The designed E19 molecule has the same tertiary structure in 
H2O that Ex4 has in a 30% TFE solution; it is more helical than Ex4 under all studied conditions, and it is less 
prone to oligomerization and meanwhile has a well-preserved biological activity. These results suggest that other 
chemical or mutational modifications that facilitate the preformation of the α-helix but prevent significant self-
association may result in more potent therapeutic drug candidates with improved pharmacokinetic properties. 
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Figure 1. Sequence alignment of class B GPCR ligands. Amino acids on a black background represent 
fully conserved residues, and amino acids on a gray background represent four to six identical residues 
among the seven listed class B GPCR ligands. Residues that interact with nGLP-1R are nderlined.9,14 
 
 
 
 
Figure 2. Far-UV ECD spectra of (a) E0−E11 (measured inH2O) and (b) TC, E19, and Ex4 (measured 
inH2Oor 30% TFE) at 5 °C. The inset in panel a displays the molar ellipticity values at 222 nm for 
each peptide (E0−E11, E19, and Ex4, all in H2O). 
 
 
 
Figure 3. (a) NOE connectivity chart of E19 displaying short- and medium-range NOEs. The thickness 
of the lines is scaled with the distance restraints. (b) Hα chemical shift deviations from their random 
coil values of E19, E10, E8, E6, E4, E2, and E0 in the E3−E28 segment. The corresponding Hα CSD 
plot of E11, E9, E7, E5, E3, and E1 is displayed in Figure S2 of the Supporting Information. 
 
 
 
Figure 4. Ribbon representations of the NMR structural ensembles of the N-terminally elongated Trp 
cage variants. 
  
 
 
Figure 5. Ribbon representation of E19 [PDB entry 2MJ9 (coral)] with (a) the Ex4 NMR structure 
[PDB entry 1JRJ (blue)] and (b) the Ex4 Xray structure [PDB entry 3C5T (orchid)]. Y22/F22, W25, 
P31, and P38 are displayed in all-atom representation. For the sake of clarity and a better comparison 
in panel b, the H atoms have been omitted from the E19 NMR structure. 
 
 
 
Figure 6. (a) J(0), (b) J(ωN), and (c) J(0.87ωH) spectral density values of TC, E5, E11, and E19 
measured at 27 °C at a B0 field strength of 11.74 T. (d) Exchange parameter ϕ vs the primary 
sequence of E19. 
 
Figure 7. Relative change in insulin secretion in the presence of 15 mM glucose and 20 nM E10, E19, 
and Ex4 compared to the response to 15 mM glucose alone in INS-1E cells. Values are presented as 
means ± the standard error of the mean. 
